|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 4/04/24 American Well Corp. 8-K:3,7,9 4/02/24 9:164K Donnelley … Solutions/FA |
Document/Exhibit Description Pages Size
1: 8-K Current Report HTML 42K
2: EX-99.1 Miscellaneous Exhibit HTML 13K
4: R1 Document And Entity Information HTML 47K
6: XML IDEA XML File -- Filing Summary XML 11K
9: XML XBRL Instance -- amwl-20240402_htm XML 15K
5: EXCEL IDEA Workbook of Financial Report Info XLSX 8K
3: EX-101.SCH XBRL Taxonomy Extension Schema With Embedded XSD 72K
Linkbases Document -- amwl-20240402
7: JSON XBRL Instance as JSON Data -- MetaLinks 11± 18K
8: ZIP XBRL Zipped Folder -- 0000950170-24-041830-xbrl Zip 15K
| 8-K |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM i 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): i April 02, 2024 |
i American Well Corporation
(Exact name of Registrant as Specified in Its Charter)
i Delaware |
i 20-5009396 |
|||
(State or Other Jurisdiction |
(Commission File Number) |
(IRS Employer |
||
|
|
|
|
|
i 75 State Street i 26th Floor |
|
|||
i Boston, i Massachusetts |
|
i 02109 |
||
(Address of Principal Executive Offices) |
|
(Zip Code) |
||
Registrant’s Telephone Number, Including Area Code: i 617 i 204-3500 |
|
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Securities registered pursuant to Section 12(b) of the Act:
|
|
Trading |
|
|
i Class A Common Stock, $0.01 Par Value |
|
i AMWL |
|
i New York Stock Exchange |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company i ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.
On April 2, 2024, American Well Corporation (the “Company”) received a notice from the New York Stock Exchange (the “NYSE”) that the Company was not in compliance with the continued listing minimum price criteria set forth in Section 802.01C of the NYSE’s Listed Company Manual (“Section 802.01C”) because the average closing price of the Company’s Class A Common Stock (the “Common Stock”) was less than $1.00 per share over a consecutive 30 trading-day period. The notice has no immediate impact on the listing of the Common Stock on the NYSE, subject to the Company’s compliance with the NYSE’s other continued listing requirements.
Pursuant to Section 802.01C, the Company has a period of six months following the receipt of the notice to regain compliance with the minimum price criteria. The Company may regain compliance at any time during the six-month cure period if, on the last trading day of any calendar month during the six-month cure period, the Common Stock has a closing price of at least $1.00 per share and an average closing price of at least $1.00 per share over the 30 trading-day period ending on the last trading day of that month.
The Company has already confirmed to the NYSE of its intent to regain compliance with the requirements of Section 802.01C, including by effecting a reverse stock split, subject to board approval and stockholder approval at its upcoming 2024 annual meeting.
The notice does not affect the Company’s business operations or its reporting obligations with the Securities and Exchange Commission.
Item 7.01 Regulation FD Disclosure.
On April 4, 2024, the Company issued a press release related to the foregoing. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference to this Item 7.01.
The information in this Item 7.01, including Exhibit 99.1, is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and is not to be incorporated by reference into any filing by Company under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language contained in such filing, unless otherwise expressly stated in such filing.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits. The following exhibit is being filed herewith:
99.1 |
|
Press Release, dated April 4, 2024, issued by American Well Corporation. |
|
|
|
104 |
|
Cover Page Interactive Data File (embedded within the Inline XBRL document). |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
AMERICAN WELL CORPORATION |
|
|
|
|
Date: |
By: |
/s/ Bradford Gay |
|
|
|
|
Bradford Gay |
| This ‘8-K’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 4/4/24 | None on these Dates | ||
| For Period end: | 4/2/24 | |||
| List all Filings | ||||